Literature DB >> 31372221

Hyaluronic Acid Grafted Nanoparticles of a Platinum(II)-Silicon(IV) Phthalocyanine Conjugate for Tumor and Mitochondria-Targeted Photodynamic Therapy in Red Light.

Koushambi Mitra1,2, Montserrat Samso3, Charles E Lyons2, Matthew C T Hartman1,2.   

Abstract

Herein, we report novel hyaluronic acid formulated nanoparticles containing a platinum(II) conjugated silicon(IV) phthalocyanine (SiPc-Pt-HA) for tumor targeted red light photodynamic therapy and chemotherapy. The SiPc-Pt-HA conjugate showed specific uptake, photo-enhanced cytotoxicity (~1500 fold) and mitochondrial accumulation in breast cancer over normal cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 31372221      PMCID: PMC6675464          DOI: 10.1039/C8TB02533A

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  51 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Platinum complexes as light promoted anticancer agents: a redefined strategy for controlled activation.

Authors:  Koushambi Mitra
Journal:  Dalton Trans       Date:  2016-12-06       Impact factor: 4.390

3.  Hematoporphyrin-derived soluble porphyrin-platinum conjugates with combined cytotoxic and phototoxic antitumor activity.

Authors:  Christian Lottner; Karl-Christian Bart; Günther Bernhardt; Henri Brunner
Journal:  J Med Chem       Date:  2002-05-09       Impact factor: 7.446

4.  Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial.

Authors:  Elma D Baron; Christi L Malbasa; Diana Santo-Domingo; Pingfu Fu; Janine D Miller; Kaija K Hanneman; Andrew H Hsia; Nancy L Oleinick; Valdir C Colussi; Kevin D Cooper
Journal:  Lasers Surg Med       Date:  2010-12       Impact factor: 4.025

5.  Molecular combo of photodynamic therapeutic agent silicon(iv) phthalocyanine and anticancer drug cisplatin.

Authors:  Jiafei Mao; Yangmiao Zhang; Jianhui Zhu; Changli Zhang; Zijian Guo
Journal:  Chem Commun (Camb)       Date:  2009-01-19       Impact factor: 6.222

6.  Near infrared fluorescent nanoparticles based on hyaluronic acid: Self-assembly, optical properties, and cell interaction.

Authors:  Sneha S Kelkar; Tanner K Hill; Frank C Marini; Aaron M Mohs
Journal:  Acta Biomater       Date:  2016-03-17       Impact factor: 8.947

7.  A Mitochondria-Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects Under Hypoxia.

Authors:  Wen Lv; Zhang Zhang; Kenneth Yin Zhang; Huiran Yang; Shujuan Liu; Aqiang Xu; Song Guo; Qiang Zhao; Wei Huang
Journal:  Angew Chem Int Ed Engl       Date:  2016-07-06       Impact factor: 15.336

Review 8.  Multi-platinum anti-cancer agents. Substitution-inert compounds for tumor selectivity and new targets.

Authors:  N P Farrell
Journal:  Chem Soc Rev       Date:  2015-05-08       Impact factor: 54.564

Review 9.  Dye Sensitizers for Photodynamic Therapy.

Authors:  Alexandra B Ormond; Harold S Freeman
Journal:  Materials (Basel)       Date:  2013-03-06       Impact factor: 3.623

10.  In-Cell Activation of Organo-Osmium(II) Anticancer Complexes.

Authors:  Russell J Needham; Carlos Sanchez-Cano; Xin Zhang; Isolda Romero-Canelón; Abraha Habtemariam; Margaret S Cooper; Levente Meszaros; Guy J Clarkson; Philip J Blower; Peter J Sadler
Journal:  Angew Chem Int Ed Engl       Date:  2016-12-21       Impact factor: 15.336

View more
  4 in total

Review 1.  Solutions to the Drawbacks of Photothermal and Photodynamic Cancer Therapy.

Authors:  Xiangyu Deng; Zengwu Shao; Yanli Zhao
Journal:  Adv Sci (Weinh)       Date:  2021-01-05       Impact factor: 16.806

Review 2.  Monofunctional Platinum(II) Anticancer Agents.

Authors:  Suxing Jin; Yan Guo; Zijian Guo; Xiaoyong Wang
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-07

Review 3.  Cancer drug resistance: rationale for drug delivery systems and targeted inhibition of HSP90 family proteins.

Authors:  Clélia Mathieu; Samir Messaoudi; Elias Fattal; Juliette Vergnaud-Gauduchon
Journal:  Cancer Drug Resist       Date:  2019-09-19

Review 4.  Photocontrolled activation of small molecule cancer therapeutics.

Authors:  M Michael Dcona; Koushambi Mitra; Matthew C T Hartman
Journal:  RSC Med Chem       Date:  2020-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.